Online Trial Tracker - Larvol Sigma

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

hydrocortisone / Generic mfg.

NCT00002494: Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

Completed

134

cyclophosphamide, cytarabine, dexamethasone, doxorubicin hydrochloride, etoposide, ifosfamide, leucovorin calcium, mesna, methotrexate, prednisone, therapeutic hydrocortisone, vincristine sulfate, low-LET cobalt-60 gamma ray therapy, low-LET photon therapy

Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)

Leukemia, Lymphoma

03/04

01/06

NCT00392834: Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma

	P2 data - ASCO
	Jun 2012 - Jun 2012: P2 data - ASCO
	P2 data in Burkitt's lymphoma
	Dec 2011 - Dec 2011: P2 data in Burkitt's lymphoma

Completed

filgrastim, pegfilgrastim, rituximab, cyclophosphamide, cytarabine, doxorubicin hydrochloride, etoposide, ifosfamide, leucovorin calcium, liposomal cytarabine, methotrexate, therapeutic hydrocortisone, vincristine sulfate

AIDS Malignancy Consortium, National Cancer Institute (NCI), The Emmes Company, LLC

Lymphoma

07/11

07/13

NCT00133991: Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia

Completed

Filgrastim, Neupogen, G-CSF, Rituximab, Rituxan, Cyclophosphamide, Cytoxan, Cy, CTX, HiCy, Cytarabine, Ara-C, Methotrexate, MTX, Prednisone, Deltasone, Hydrocortisone, Vincristine, Oncovin, Leucovorin, Folinic acid

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, National Cancer Institute (NCI)

Leukemia, Lymphoma

08/11

08/13



	Diseases Companies Products Productz Mechanisms of Action Sites